References
- Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., Siva, S., Bekker, L. G., Jeenarain, N., Gaffoor, Z., Martinson, F., Makanani, B., Pather, A., Naidoo, L., Husnik, M., … Team, M.-A. S. (2016). Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New England Journal of Medicine, 375(22), 2121–2132. https://doi.org/10.1056/NEJMoa1506110
- Brown, E. R., Hendrix, C. W., van der Straten, A., Kiweewa, F. M., Mgodi, N. M., Palanee-Philips, T., Marzinke, M. A., Bekker, L. G., Soto-Torres, L., Hillier, S. L., Baeten, J. M., & Team, M.-A. S. (2020). Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: A secondary analysis from a randomized, placebo-controlled trial. Journal of the International AIDS Society, 23(11), e25634. https://doi.org/10.1002/jia2.25634
- Griffin, J. B., Ridgeway, K., Montgomery, E., Torjesen, K., Clark, R., Peterson, J., Baggaley, R., & van der Straten, A. (2019). Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS One, 14(11), e0224898. https://doi.org/10.1371/journal.pone.0224898
- Gwarisa, M. (2021). #BREAKING: Dapivirine, vaginal ring approved for use in Zimbabwe. The Health Times. https://healthtimes.co.zw/2021/07/14/breaking-dapivirine-vaginal-ring-approved-for-use-in-zimbabwe/
- Hensen, B., Chabata, S. T., Floyd, S., Chiyaka, T., Mushati, P., Busza, J., Birdthistle, I., Hargreaves, J. R., & Cowan, F. M. (2019). HIV risk among young women who sell sex by whether they identify as sex workers: Analysis of respondent-driven sampling surveys, Zimbabwe, 2017. Journal of the International AIDS Society, 22(12), e25410. https://doi.org/10.1002/jia2.25410
- Hensen, B., Machingura, F., Busza, J., Birdthistle, I., Chabata, S. T., Chiyaka, T., Floyd, S., Jamali, G., Mushati, P., Hargreaves, J., & Cowan, F. M. (2021). How can we support the use of oral PrEP among young women who sell sex? A PrEP cascade analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 88(1), 45–56. https://doi.org/10.1097/QAI.0000000000002733
- IPM’s dapivirine ring for women’s HIV prevention receives WHO prequalification. (2020). International partnership for microbicides.
- Kilburn, K., Ranganathan, M., Stoner, M. C. D., Hughes, J. P., MacPhail, C., Agyei, Y., Gomez-Olive, F. X., Kahn, K., & Pettifor, A. (2018). Transactional sex and incident HIV infection in a cohort of young women from rural South Africa. AIDS, 32(12), 1669–1677. https://doi.org/10.1097/QAD.0000000000001866
- Mayo, A. J., Browne, E. N., Montgomery, E. T., Torjesen, K., Palanee-Phillips, T., Jeenarain, N., Seyama, L., Woeber, K., Harkoo, I., Reddy, K., Tembo, T., Mutero, P., Tauya, T., Chitukuta, M., Gati Mirembe, B., Soto-Torres, L., Brown, E. R., Baeten, J. M., & van der Straten, A. (2021). Acceptability of the dapivirine vaginal ring for HIV-1 prevention and association with adherence in a phase III trial. AIDS and Behavior, 25(8), 2430–2440. https://doi.org/10.1007/s10461-021-03205-z
- Mensch, B. S., van der Straten, A., & Katzen, L. L. (2012). Acceptability in microbicide and PrEP trials: Current status and a reconceptualization. Current Opinion in HIV and AIDS, 7(6), 534–541. https://doi.org/10.1097/COH.0b013e3283590632
- Mishra, S., Boily, M. C., Schwartz, S., Beyrer, C., Blanchard, J. F., Moses, S., Castor, D., Phaswana-Mafuya, N., Vickerman, P., Drame, F., Alary, M., & Baral, S. D. (2016). Data and methods to characterize the role of sex work and to inform sex work programs in generalized HIV epidemics: Evidence to challenge assumptions. Annals of Epidemiology, 26(8), 557–569. https://doi.org/10.1016/j.annepidem.2016.06.004
- Montgomery, E. T., van der Straten, A., Chitukuta, M., Reddy, K., Woeber, K., Atujuna, M., Bekker, L. G., Etima, J., Nakyanzi, T., Mayo, A. J., Katz, A., Laborde, N., Grossman, C. I., Soto-Torres, L., Palanee-Phillips, T., Baeten, J. M., & Study, M.-A. (2017). Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS, 31(8), 1159–1167. https://doi.org/10.1097/QAD.0000000000001452
- Nel, A., van Niekerk, N., Kapiga, S., Bekker, L. G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., Miti, N., Kusemererwa, S., Tempelman, H., Carstens, H., Devlin, B., Isaacs, M., Malherbe, M., Mans, W., Nuttall, J., … Ring Study, T. (2016). Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. New England Journal of Medicine, 375(22), 2133–2143. https://doi.org/10.1056/NEJMoa1602046
- Ridgeway, K., Montgomery, E. T., Smith, K., Torjesen, K., van der Straten, A., Achilles, S. L., & Griffin, J. B. (2022). Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception, 106, 16–33. https://doi.org/10.1016/j.contraception.2021.10.001
- Roberts, S. T., Nair, G., Baeten, J. M., Palanee-Philips, T., Schwartz, K., Reddy, K., Kabwigu, S., Matovu Kiweewa, F., Govender, V., Gaffoor, Z., Singh, N., Siva, S., Naidoo, K., & Montgomery, E. T. (2020). Impact of male partner involvement on women’s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial. AIDS and Behavior, 24(5), 1432–1442. https://doi.org/10.1007/s10461-019-02707-1
- UNAIDS. (2018a). Miles to go: Closing gaps breaking barrier righting injustices. https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf
- UNAIDS. (2018b). Transactional sex and HIV risk: From analysis to action. Joint United Nations Programme on HIV/AIDS and STRIVE.
- Wamoyi, J., Stobeanau, K., Bobrova, N., Abramsky, T., & Watts, C. (2016). Transactional sex and risk for HIV infection in sub-Saharan Africa: A systematic review and meta-analysis. Journal of the International AIDS Society, 19(1), 20992. https://doi.org/10.7448/IAS.19.1.20992